PLUS - 医索

找到约 86 条结果

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma An Open-Label, Single-Arm, Phase II Study

医客学院 - 药物研究

Trifluridinetipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer The phase 3 randomized SU

医客学院 - 会议报告集

Real-world effectiveness and safety of trifluridinetipiracil plus bevacizumab in metastatic colorectal cancer

医客学院 - 会议报告集

Rationale 305 Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of GC GEJC

医客学院 - 会议报告集

Panitumumab plus trifluridinetipiracil as third-line anti-EGFR rechallenge therapy in chemo-refractory RAS WT metastatic colorectal

医客学院 - 会议报告集

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for GCGEJCEAC 3-year follow-up from CheckMate 649

医客学院 - 会议报告集

Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for ESCC

医客学院 - 会议报告集

Nab-paclitaxel plus anti–PD-1 antibody as second-line treatment for advanced biliary tract cancer An investigator-initiated phase 2

医客学院 - 会议报告集

First-line lenvatinib plus pembrolizumab plus chemotherapy versus chemotherapy in advancedmetastatic gastroesophageal adenocarcinoma

医客学院 - 会议报告集

Cost-effectiveness of gemcitabine plus cisplatin with and without durvalumab in patients with advanced cholangiocarcinoma

医客学院 - 会议报告集

今日实时热搜